[Upcoming Lecture] Antimicrobial Resistance (AMR) Seminar: Lessons from Semmelweis (Japan Medical Association office, Tokyo, Bunkyo-ku, November 22, 2019)
date : 11/5/2019
HGPI and its co-hosts the Japan Pharmaceutical Manufacturers Association(JPMA) and Japan Medical Association (JMA) will host a lecture aimed at healthcare providers, representatives from the government, and members of civil society entitled “Antimicrobial Resistance (AMR) Seminar: Lessons from Semmelweis.”
HGPI Chairman Dr. Kiyoshi Kurokawa will speak on the theme “The History of Infectious Disease and Current Challenges – Lessons from the Teachings of Semmelweis” and Adjunct Fellow Ms. Kaoru Matsuzawa and HGPI Board Member and CEO Mr. Ryoji Noritake will serve as moderators for a panel discussion.
■Program
Date & Time: Friday, November 22, 2019, 14:00-17:00 (Doors open at 13:30)
Venue: Japan Medical Association Office , Small Auditorium
Participation fee: Free
Capacity: 200 people
For program details, please see the PDF linked below.
To register, please fax or mail the registration form included in the PDF. To register online, please see the AMR Seminar website.
*It can be accessed in Japanese.
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
-
2024-10-30
[Event Report] Advisory Board Meeting for Meaningful Involvement Promotion Project “Promoting People with Lived Experience Participation in Policy-Making: Building a Social Foundation for Proactive Engagement” (September 11, 2024)
-
2024-10-31
[HGPI Policy Column] (No.49) From the Mental Health Project ”Changes in the Japanese Mental Health Policy and Future Policy Topics” (The 2nd part ”Issues surrounding long-term hospitalization and future policy topics”)